Lazard Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,104
Closed -$275K 2290
2025
Q1
$275K Buy
26,104
+19,414
+290% +$308K ﹤0.01% 1556
2024
Q4
$112K Sell
6,690
-2,299
-26% -$43.3K ﹤0.01% 1767
2024
Q3
$207K Buy
8,989
+39
+0.4% +$834 ﹤0.01% 1598
2024
Q2
$216K Sell
8,950
-10,489
-54% -$318K ﹤0.01% 1530
2024
Q1
$655K Sell
19,439
-8,439
-30% -$299K ﹤0.01% 1004
2023
Q4
$877K Buy
27,878
+18,161
+187% +$432K ﹤0.01% 977
2023
Q3
$247K Sell
9,717
-2,217
-19% -$68.3K ﹤0.01% 1311
2023
Q2
$341K Buy
11,934
+2,632
+28% +$71.6K ﹤0.01% 1204
2023
Q1
$222K Buy
9,302
+987
+12% +$17.7K ﹤0.01% 1280
2022
Q4
$140K Sell
8,315
-666
-7% -$11.6K ﹤0.01% 1392
2022
Q3
$133K Buy
+8,981
New +$151K ﹤0.01% 1364

Other funds holding ARCT